NPHC Financials 07/16/2014 02:39:25 Nutra Pharma

NPHC Financials 07/16/2014 02:39:25
Nutra Pharma Corp.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 122 203 160 1,432
Cost of Revenue 41 148 880 617
Gross Profit 81 56 (720) 815
Operating Expenses
Research and Development - - 91 192
Sales, General and Admin. 2,442 2,657 3,040 3,946
Non-Recurring Items - - 100 -
Other - - - -
Operating Income (2,361) (2,601) (3,951) (3,396)
Income From Continuing Operations
Add'l Income/Expense Items (1,824) (858) (23) 335
Earnings Before Interest and Tax (4,186) (3,459) (3,973) (2,987)
Interest Expense 157 153 424 74
Earnings Before Tax (4,343) (3,612) (4,397) (3,061)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,343) (3,612) (4,397) (3,061)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (4,343) (3,612) (4,397) (3,061)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (4,343) (3,612) (4,397) (3,061)